Neuphoria Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-14.6M | $-14.6M | — | $1.3M |
| FY2024 | $-14.7M | $-14.7M | — | $814.8K |
| FY2025 | $77.2K | $77.2K | — | $163.8K |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-14.6M | $-14.6M | — | $1.3M |
| FY2024 | $-14.7M | $-14.7M | — | $814.8K |
| FY2025 | $77.2K | $77.2K | — | $163.8K |